Information:
Error:
ID
38249
Description
Diffuse Optical Tomography (DOT) for Monitoring Response to Neoadjuvant (Preoperative) Chemotherapy in Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01394315
Link
https://clinicaltrials.gov/show/NCT01394315
Keywords
Versions (1)
- 10/2/19 10/2/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
October 2, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Neoplasms NCT01394315
Eligibility Breast Neoplasms NCT01394315
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT01394315
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Neoadjuvant Chemotherapy Breast Carcinoma
Item
patients receiving neoadjuvant chemotherapy for breast cancer.
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C3665472 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
Locally advanced breast cancer | Large tumor Operable | Neoadjuvant Therapy Required
Item
patients with locally advanced breast tumours or large operable tumours who require neoadjuvant treatment for downstaging.
boolean
C3495949 (UMLS CUI [1])
C0475278 (UMLS CUI [2,1])
C0205188 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0475278 (UMLS CUI [2,1])
C0205188 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
Invasive carcinoma of breast
Item
histological confirmation of invasive breast carcinoma.
boolean
C0853879 (UMLS CUI [1])
Neoplasm Metastasis | Neoplasm Metastasis minor | Operation on breast Planned | Status post Neoadjuvant Chemotherapy
Item
patients with metastatic disease may be eligible if they have oligometastatic disease and breast surgery after neoadjuvant chemotherapy is planned.
boolean
C0027627 (UMLS CUI [1])
C0027627 (UMLS CUI [2,1])
C0205165 (UMLS CUI [2,2])
C3714726 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C3665472 (UMLS CUI [4,3])
C0027627 (UMLS CUI [2,1])
C0205165 (UMLS CUI [2,2])
C3714726 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0600558 (UMLS CUI [4,2])
C3665472 (UMLS CUI [4,3])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age equal to or more than 21 years
boolean
C0001779 (UMLS CUI [1])
Life Expectancy
Item
life expectancy greater than 12 weeks.
boolean
C0023671 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Fungating tumor | Ulcerated tumor
Item
fungating or ulcerated tumours
boolean
C1446352 (UMLS CUI [1])
C1276438 (UMLS CUI [2])
C1276438 (UMLS CUI [2])
Informed Consent Unable
Item
inability to provide informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])
Follow-up Unable Anticipated
Item
anticipated inability to follow-up patient for response to chemotherapy
boolean
C3274571 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C3840775 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,2])
C3840775 (UMLS CUI [1,3])
Medical contraindication Ultrasonography | Medical contraindication MRI | Medical contraindication Mammography | Medical contraindication Diffuse Optical Tomography
Item
any contraindication to undergoing ultrasound, mri, mmg or dot
boolean
C1301624 (UMLS CUI [1,1])
C0041618 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0024671 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C1328868 (UMLS CUI [4,2])
C0041618 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0024485 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0024671 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C1328868 (UMLS CUI [4,2])